
Sotorasib improves PFS versus docetaxel in patients with pre-treated KRAS G12C-mutated NSCLC
Read more
Could anti-PD-L1 be the best choice as front-line therapy in platinum-ineligible patients with NSCLC?
Read more
The first randomised study of peptide receptor radionuclide therapy in pancreatic NETs met its primary endpoint
Read more